Fred E. Cohen
Director, Genomic Health.
Companies
- Kyverna Therapeutics, Inc.Board member Feb 7, 2024 to now1
- Intellia TherapeuticsBoard member Jan 24, 2019 to now2
- CareDx, IncBoard member Jul 16, 2014 to now3
- UroGen Pharma Ltd.Board member Jan 10, 2019 to Aug 8, 20244
- Progyny, Inc.Board member Oct 24, 2019 to May 28, 20245
- VERACYTE, INC.Board member Oct 29, 2013 to Oct 20, 20206
- Genomic HealthBoard member Sep 20, 2006 to Nov 14, 20197
- Tandem Diabetes Care, Inc.Board member Nov 13, 2013 to Nov 19, 20188
- BioCryst PharmaceuticalsBoard member Jul 24, 2013 to Jun 22, 20189
- IQVIA Holdings, Inc.Board member May 8, 2013 to May 8, 201310
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kyverna Therapeutics, Inc. KYTX4,545,651 shares11$27.1M at $5.97May 29, 2026
CareDx, Inc CDNA165,060 shares12$10.6M at $64.00Jun 12, 2026- UroGen Pharma Ltd. URGN69,339 shares13$2.5M at $36.36Jul 26, 2023
Intellia Therapeutics NTLA216,653 shares14$2.5M at $11.34Jun 9, 2026Progyny, Inc. PGNY22,693 shares15$623.0K at $27.45May 23, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 12, 2026Granted 9,795 shares of CareDx, Inc12
- Jun 9, 2026Granted 9,200 shares of Intellia Therapeutics14
- May 27, 2026Granted 5,093 shares of Kyverna Therapeutics, Inc.11
- Jan 5, 2026Bought 150,000 shares at $9.35 of Intellia Therapeutics16
- Jun 13, 2025Granted 12,103 shares of CareDx, Inc17
- Jun 11, 2025Granted 8,000 shares of Intellia Therapeutics18
- May 29, 2025Granted 16,634 shares of Kyverna Therapeutics, Inc.19
- Jun 14, 2024Granted 10,570 shares of CareDx, Inc20
- Jun 12, 2024Granted 7,737 shares of Intellia Therapeutics21
- May 23, 2024Granted 6,176 shares of Progyny, Inc.15
- Feb 12, 2024Converted 4,523,924 shares of Kyverna Therapeutics, Inc.22
- Jul 26, 2023Granted 69,339 shares at $9.54 of UroGen Pharma Ltd.13
- Jun 16, 2023Granted 18,844 shares of CareDx, Inc23
- Jun 14, 2023Granted 4,425 shares of Intellia Therapeutics24
- May 24, 2023Granted 4,385 shares of Progyny, Inc.25
- Jan 6, 2023Granted 1,062 shares of CareDx, Inc26
- Oct 24, 2022Granted 3,480 shares of Progyny, Inc.27
- Oct 4, 2022Granted 803 shares of CareDx, Inc28
- Jun 16, 2022Granted 4,863 shares of CareDx, Inc29
- Jun 14, 2022Granted 5,197 shares of Intellia Therapeutics30
- Oct 24, 2021Granted 2,652 shares of Progyny, Inc.31
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARIntellia Therapeutics, Board member
- 3SEC EDGARCareDx, Inc, Board member
- 4SEC EDGARUroGen Pharma Ltd., Board member
- 5SEC EDGARProgyny, Inc., Board member
- 6SEC EDGARVERACYTE, INC., Board member
- 7SEC EDGARGenomic Health, Board member
- 8
- 9
- 10SEC EDGARIQVIA Holdings, Inc., Board member
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARForm 4 filed Jan 7, 2026
- 17SEC EDGARForm 4 filed Jun 17, 2025
- 18SEC EDGARForm 4 filed Jun 13, 2025
- 19SEC EDGARForm 4 filed Jun 2, 2025
- 20SEC EDGARForm 4 filed Jun 18, 2024
- 21SEC EDGARForm 4 filed Jun 14, 2024
- 22SEC EDGARForm 4 filed Feb 14, 2024
- 23SEC EDGARForm 4 filed Jun 21, 2023
- 24SEC EDGARForm 4 filed Jun 16, 2023
- 25SEC EDGARForm 4 filed May 26, 2023
- 26SEC EDGARForm 4 filed Jan 9, 2023
- 27SEC EDGARForm 4 filed Oct 26, 2022
- 28SEC EDGARForm 4 filed Oct 4, 2022
- 29SEC EDGARForm 4 filed Jun 21, 2022
- 30SEC EDGARForm 4 filed Jun 16, 2022
- 31SEC EDGARForm 4 filed Oct 26, 2021